Axogen (AXGN) EPS (Diluted) Growth (5y) (2015 - 2026)
Axogen (AXGN) EPS (Diluted) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Axogen | 2.10 Bn | 2.00 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97% |
| Dec 31, 2025 | -10.95% |
| Sep 30, 2025 | 15.24% |
| Jun 30, 2025 | 56.00% |
| Mar 31, 2025 | 18.68% |
| Dec 31, 2024 | 63.51% |
| Sep 30, 2024 | 49.62% |
| Jun 30, 2024 | 52.44% |
| Mar 31, 2024 | 41.88% |
| Dec 31, 2023 | 29.29% |
| Sep 30, 2023 | 34.08% |
| Jun 30, 2023 | 30.71% |
| Mar 31, 2023 | 31.48% |
| Dec 31, 2022 | 33.88% |
| Sep 30, 2022 | 21.77% |
| Jun 30, 2022 | 13.96% |
| Mar 31, 2022 | 18.98% |
| Dec 31, 2021 | -36.43% |
| Sep 30, 2021 | 18.44% |
| Jun 30, 2021 | 21.31% |